Survey of Ohio Pharmacists' Perception of a PharmD/MDA Degree
Matthew Gecks, Devon Taylor, Brandon Rhoades, Devin Rogers, Akesha Edwards
Abstract
Telehealth is referred to as the remote interactions between health care providers and patients The purpose of this study is to gather information on the perception of pharmacists about dual PharmD/MBA degrees. Findings from this study would contribute to identifying 1) if there is a need for Colleges of Pharmacy to enhance offerings in their curricula related to business and 2) if certain pharmacy occupations favored candidates with a PharmD/MBA over just a PharmD. Surveys were emailed to all Ohio licensed pharmacists (n = 20,553). 711 pharmacists responded (response rate of 3.5%) to the survey which asked pharmacists about their perceptions of the benefits of a PharmD/MBA dual degree. Only 108 pharmacists had an MBA or an additional business degree, such as Healthcare Administration, Finance, or Accounting (15.2%). Attitudes toward the credibility of pharmacists with an MBA were neutral (60.0%) and about one third of them viewed pharmacists with an MBA as more credible than those without an MBA (35.9%). When asked to rate on a scale of 1-5 how much an MBA has or would have helped their career, in their opinion, the most likely Pharmacy professionals to rate the MBA as more useful (4-5) had careers in Academia (mean 3.375, n=32), Independent Community (mean 3.524, n=63), Industry (mean 3.636, n=11), and Managed Care (mean 4.563, n=16). Obtaining an MBA with a PharmD can be a difficult task and may not be perceived as useful to every pharmacist. However, there are groups of people that value a PharmD/MBA which corresponds to more use in their respective area of pharmacy. Business concepts are important in pharmacy practice and a dual degree could help progress more niche areas of pharmacy practice.
Full Text
volume5article3.pdf
File Size: 1026 kb
File Type: pdf
Download File

Notice and Disclaimer

Medicine is an ever-changing science.  As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required.  The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.  However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work.    Readers are encouraged to confirm the information contained herein with other sources.   For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.

Subscribe to ARxCH